Delivery Order SPE2DB20D3103-SPE2DB22FP2C0
Award Date 7/14/22
Potential Completion Date 7/15/22
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Atorvastatin 20 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $6,040.27 and a completion date of May 5, 2022. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award is for the delivery of Atorvastatin 80 mg tablets to the Defense Logistics Agency (DLA). The $2,524.50 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 22, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 500 tablets of Atorvastatin 80 mg. The contract, valued at $1,959.14, is a firm fixed-price delivery order with a completion date of January 12, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award, valued at $1,228.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,906,764 units of Atorvastatin 40 mg tablets, a common cardiovascular medication. The award does not utilize any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $3,223.60, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of 4,562,417,388 units of Atorvastatin 40 mg tablets, with a period of performance through October 10, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,011.22, is for the delivery of 4560784583 units of Atorvastatin 40 mg tablets to support military healthcare programs. The award is a Delivery Order contract with a firm-fixed price pricing type, with a completion date of May 2, 2023. This contract is not designated as a set-aside and was...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,502.25 firm-fixed-price contract is for the delivery of Atorvastatin 40 mg tablets. The contract has an ultimate completion date of July 15, 2022 and was awarded on July 14, 2022. This contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a...
- This federal contract award, valued at $2,337.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atorvastatin 20 mg tablets in quantities of 1,000 per order, with a completion date of November 22, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical,...
- This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the procurement of 1,000 units of Atorvastatin 40 mg tablets. The firm-fixed price contract has a ceiling value of $2,102.16 and a period of performance ending on November 6, 2023. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,080.94 delivery order contract is for the supply of 4,568,190,570 units of the prescription medication Atorvastatin 80 mg tablets. The award is not set aside and is a firm fixed price contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...